Invesco
CELL

Invesco’s PhenomeX Inc. Common Stock CELL Stock Holding History

Invesco’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,074
Closed -$17.5K – 3990
2023
Q1 		$17.5K Sell
15,074
-1,006
-6% -$1.84K ﹤0.01% 3821
2022
Q4 		$43.1K Buy
16,080
+76
+0.5% +$200 ﹤0.01% 3919
2022
Q3 		$46K Sell
16,004
-243
-1% -$1.03K ﹤0.01% 3924
2022
Q2 		$81K Sell
16,247
-927
-5% -$4.86K ﹤0.01% 3920
2022
Q1 		$122K Sell
17,174
-2,784,004
-99% -$23M ﹤0.01% 3851
2021
Q4 		$50.9M Buy
2,801,178
+1,322,395
+89% +$28.5M 0.01% 1039
2021
Q3 		$28.9M Buy
1,478,783
+825,350
+126% +$31.4M 0.01% 1325
2021
Q2 		$29.3M Buy
653,433
+641,022
+5,165% +$29.7M 0.01% 1381
2021
Q1 		$624K Buy
12,411
+5,062
+69% +$345K ﹤0.01% 3250
2020
Q4 		$657K Buy
7,349
+581
+9% +$48.9K ﹤0.01% 3110
2020
Q3 		$516K Buy
+6,768
New +$430K ﹤0.01% 3112

Other funds holding CELL

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
NIMC
Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco's CELL Position: Q2 2023 in Review

Invesco sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 15,074 shares — an estimated $17.5K sold.

Invesco first reported a position in CELL in Q3 2020 and held it in 11 quarters. The position peaked at $50.9M in Q4 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Invesco reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Invesco sold 15,074 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $17.5K.
  • Invesco first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Invesco's PhenomeX Inc. Common Stock position peaked at $50.9M in Q4 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Invesco's 13F filing for Q2 2023, filed 11 Aug 2023.